Physician–Patient Communication About Prescription Medication Nonadherence: A 50-state Study of America’s Seniors
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Understanding and improving the quality of medication management is particularly important in the context of the Medicare prescription drug benefit that took effect last January 2006.
To determine the prevalence of physician–patient dialogue about medication cost and medication adherence among elderly adults nationwide.
National stratified random sample of community-dwelling Medicare beneficiaries aged 65 and older.
Main Outcome Measures
Rates of physician–patient dialogue about nonadherence and cost-related medication switching.
Forty-one percent of seniors reported taking five or more prescription medications, and more than half has 2 or more prescribing physicians. Thirty-two percent overall and 24% of those with 3 or more chronic conditions reported not having talked with their doctor about all their different medicines in the last 12 months. Of seniors reporting skipping doses or stopping a medication because of side effects or perceived nonefficacy, 27% had not talked with a physician about it. Of those reporting cost-related nonadherence, 39% had not talked with a physician about it. Thirty-eight percent of those with cost-related nonadherence reported switching to a lower priced drug, and in a multivariable model, having had a discussion about drug cost was significantly associated with this switch (odds ratio [OR] 5.04, 95% confidence interval [CI] 4.28–5.93, P < .001).
We show that there is a communication gap between seniors and their physicians around prescription medications. This communication problem is an important quality and safety issue, and takes on added salience as physicians and patients confront new challenges associated with coverage under new Medicare prescription drug plans. Meeting these challenges will require that more attention be devoted to medication management during all clinical encounters.
- Anderson GF. Medicare and chronic conditions. N Engl J Med. 2005;353(3):305–9. CrossRef
- Pear R. 17 Percent Increase in Prescription Drug Costs Hit Elderly Hardest, Study Finds. New York: The New York Times; 27 Jun 2000.
- Strunk BC, Ginsburg PB, Gabel JR. Tracking health care costs. Health Aff. 2002;suppl:W39–W50.
- Gross DJ, Schondelmeyer SW, Raetzman SO. Trends in manufacturer prices of brand name prescription drugs used by older Americans—first quarter 2004 update. Issue Brief (Public Policy Inst (Am Assoc Retired Pers)) 2004;(IB69):1–2.
- Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16. CrossRef
- Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714–20.
- Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med. 2004;164(3):305–12. CrossRef
- Zhan C, Correa-de-Araujo R, Bierman AS, et al. Suboptimal prescribing in elderly outpatients: potentially harmful drug–drug and drug–disease combinations. J Am Geriatr Soc. 2005;53(2):262–7. CrossRef
- Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16:793–9. CrossRef
- Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: How well are states closing the gap. Health Aff (Millwood). 2002;W253–67.
- Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically III adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94(10):1782–7. CrossRef
- Wilson IB, Rogers WH, Chang H, Safran DG. Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Results of a national study. J Gen Intern Med. 2005;20(8):715–20. CrossRef
- Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164(16):1749–55. CrossRef
- Alexander GC, Casalino LP, Meltzer DO. Patient–physician communication about out-of-pocket costs. JAMA. 2003;290(7):953–8. CrossRef
- Mays J, Brenner M, NeumanT CJCG. Estimates of Medicare Beneficiaries’ Out-of-pocket Drug Spending in 2006 (# 7201). Menlo Park, USA: Kaiser Family Foundation; 24 Nov 2004.
- Kaiser Family Foundation. The Kaiser Family Foundation Health Poll Report Survey: Findings on the New Medicare Drug Law. Menlo Park, USA: Kaiser Family Foundation; 2005.
- Kaiser Family Foundation. Seniors’ Early Experiences with the Medicare Prescription Drug Benefit—April 2006 (# 7501). Menlo Park, USA: Kaiser Family Foundation; 25 Apr 2006.
- Dillman DA. Mail and Telephone Surveys: the Total Design Method. New York: John Wiley & Sons; 1978.
- Fowles JB, Fowler EJ, Craft C. Validation of claims diagnoses and self-reported conditions compared with medical records for selected chronic diseases. J Ambul Care Manage. 1998;21(1):24–34.
- Buck SF. A method of estimation of missing values in multivariate data suitable for use with an electronic computer. J R Stat Soc. 1960;B22:302–6.
- Rogers WH, Qian S, Kazis L. Imputing PCS and MCS in the Presence of Missing Data. Bedford, MA: Center for Health Quality, Outcomes, and Economic Research; 2003.
- Jones MP. Indicator and stratification methods for missing explanatory variables in multiple linear regression. J Am Stat Assoc. 1996;91:222–30. CrossRef
- Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–64. CrossRef
- Weingart SN, Gandhi TK, Seger AC, et al. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165(2):234–40. CrossRef
- Safran DG, Neuman P, Schoen C, et al. Prescription Drug Coverage and Seniors: Findings From A 2003 National Survey. Health Aff (Millwood). 2005;24W5.152–66
- Andersson K, Sonesson C, Petzold M, Carlsten A, Lonnroth K. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf. 2005;14(5):341–8. CrossRef
- Bradley CP, Riaz A, Tobias RS, Kenkre JE, Dassu DY. Patient attitudes to over-the-counter drugs and possible professional responses to self-medication. Fam Pract. 1998;15(1):44–50. CrossRef
- Brennan TA, Lee TH. Allergic to generics. Ann Intern Med. 2004;141(2):126–30.
- U.S. Food and Drug Administration. FDA Assures Equivalence of Generic Drugs. USA: FDA; 2002.
- Van Wijk BL, Klungel OH, Heerdink ER, de BA. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother. 2005;39(2):319–28. CrossRef
- Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20(11):817–32. CrossRef
- Beney J, Bero LA, Bond C. Expanding the roles of outpatientpharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;(3):CD000336.
- Avorn J. Part “D” for “defective”—the Medicare drug–benefit chaos. N Engl J Med. 2006;354(13):1339–41. CrossRef
- Kaiser Family Foundation. The Transition of Dual Eligibles to Medicare Part D Prescription Drug Coverage (7467). Menlo Park, USA: Kaiser Family Foundation; 28 Feb 2006.
- Pear R. Medicare Woes Take High Toll on Mentally Ill. New York: New York Times (online); 21 Jan 2006.
- Berenson A. Drug Plan’s Side Effect is Severe. New York: New York Times (online); 8 Apr 2006.
- Physician–Patient Communication About Prescription Medication Nonadherence: A 50-state Study of America’s Seniors
Journal of General Internal Medicine
Volume 22, Issue 1 , pp 6-12
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- physician–patient relations
- pharmaceutical services
- patient compliance
- Industry Sectors
- Author Affiliations
- 1. Tufts–New England Medical Center, 750 Washington Street, Box 345, Boston, MA, 02111, USA
- 2. The Commonwealth Fund, New York, USA
- 3. The Henry J. Kaiser Family Foundation, Menlo Park, USA